XML 42 R28.htm IDEA: XBRL DOCUMENT
v3.23.1

Significant Accounting Policies (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2023
Accounting Policies [Abstract] |
Schedule of the impact of the immaterial correction of an error | The condensed consolidated financial statements as of and for the three and nine months ended March 31, 2022 have been adjusted as shown in the following tables.
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended
​ | ​ | March 31, 2022
​ | ​ | As Previously | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Reported | ​ | Adjustment | ​ | As Adjusted
​ | ​ | (in thousands)
Statement of Operation data | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Gain on derivative warrant liabilities | ​ | $ | 211 | ​ | $ | (218) | ​ | $ | (7)
Total other (expense) income (1) | ​ | $ | 348 | ​ | $ | (218) | ​ | $ | 130
Loss before income tax | ​ | $ | (53,073) | ​ | $ | (218) | ​ | $ | (53,291)
Net loss | ​ | $ | (53,073) | ​ | $ | (218) | ​ | $ | (53,291)
Basic and diluted net loss per common share | ​ | $ | (35.80) | ​ | $ | (0.10) | ​ | $ | (35.90)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Statement of Stockholders' Equity data | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Issuance of common stock, net of issuance cost | ​ | $ | 7,034 | ​ | $ | (3,178) | ​ | $ | 3,856
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss by segment | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Rx Segment | ​ | $ | (52,311) | ​ | $ | (218) | ​ | $ | (52,529)
Consumer Health Segment | ​ | ​ | (762) | ​ | ​ | — | ​ | ​ | (762)
Consolidated net loss | ​ | $ | (53,073) | ​ | $ | (218) | ​ | $ | (53,291)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(1) Includes reclassification of gain or loss from fair value of contingent consideration. See Prior Period Reclassification in Note 1 – Nature of Business, Financial Condition, Basis of Presentation.
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Nine Months Ended
​ | ​ | March 31, 2022
​ | ​ | As Previously | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Reported | ​ | Adjustment | ​ | As Adjusted
​ | ​ | (in thousands)
Statement of Operation data | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Gain on derivative warrant liabilities | ​ | $ | 211 | ​ | $ | (218) | ​ | $ | (7)
Total other (expense) income (1) | ​ | $ | 384 | ​ | $ | (218) | ​ | $ | 166
Loss before income tax | ​ | $ | (92,582) | ​ | $ | (218) | ​ | $ | (92,800)
Net loss | ​ | $ | (92,472) | ​ | $ | (218) | ​ | $ | (92,690)
Basic and diluted net loss per common share | ​ | $ | (68.00) | ​ | $ | (0.13) | ​ | $ | (68.13)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Statement of Cash Flow data | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss | ​ | $ | (92,472) | ​ | $ | (218) | ​ | $ | (92,690)
Gain on derivative warrant liabilities | ​ | $ | (211) | ​ | $ | 218 | ​ | $ | 7
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss by segment | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Rx Segment | ​ | $ | (88,359) | ​ | $ | (218) | ​ | $ | (88,577)
Consumer Health Segment | ​ | ​ | (4,113) | ​ | ​ | — | ​ | ​ | (4,113)
Consolidated net loss | ​ | $ | (92,472) | ​ | $ | (218) | ​ | $ | (92,690)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(1) Includes reclassification of gain or loss from fair value of contingent consideration. See Prior Period Reclassification in Note 1 – Nature of Business, Financial Condition, Basis of Presentation. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | As of March 31, 2022
​ | ​ | As Previously | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Reported | ​ | Adjustment | ​ | As Adjusted
​ | ​ | (in thousands)
Statement of Stockholders' Equity data | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Additional paid-in capital | ​ | $ | 331,915 | ​ | $ | (3,178) | ​ | $ | 328,737
Accumulated deficit | ​ | ​ | (270,771) | ​ | ​ | (218) | ​ | ​ | (270,989)
Total stockholders’ equity | ​ | $ | 61,144 | ​ | $ | (3,396) | ​ | $ | 57,748
​ The consolidated balance sheet and the consolidated statement of stockholders’ equity as of June 30, 2022 have been adjusted as shown in the table below.
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | As of June 30, 2022
​ | ​ | As Previously | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Reported | ​ | Adjustment | ​ | As Adjusted
​ | ​ | (in thousands)
Derivative warrant liabilities | ​ | $ | — | ​ | $ | 1,796 | ​ | $ | 1,796
Total liabilities | ​ | $ | 91,531 | ​ | $ | 1,784 | ​ | $ | 93,315
Additional paid-in capital | ​ | $ | 334,560 | ​ | $ | (3,174) | ​ | $ | 331,386
Accumulated deficit | ​ | $ | (288,472) | ​ | $ | 1,394 | ​ | $ | (287,078)
Total stockholders’ equity | ​ | $ | 46,092 | ​ | $ | (1,784) | ​ | $ | 44,308

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794 + Details
Name: | us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration